Peter Salzmann
Chief Executive Officer at IMMUNOVANT, INC.
Net worth: 29 M $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Yuval Cohen | M | 49 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 11 years |
Alan Holmer | M | 74 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 10 years |
Julia G. Butchko | M | 53 | 5 years | |
Atul Pande | M | 69 |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | 5 years |
Robert Discordia | M | 60 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 6 years |
John Jenkins | M | 66 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 6 years |
Jacques Suzanne | F | 53 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 5 years |
George Migausky | M | 69 |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | 5 years |
David Hochman | M | 49 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 8 years |
Sean Moran | M | 66 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 10 years |
Avery Catlin | M | 75 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 10 years |
Douglas Hughes | M | 62 |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | 5 years |
Marschall Runge | M | 69 | 11 years | |
Yong Ben | M | 50 | 1 years | |
Anne Altmeyer | M | 59 | 2 years | |
Karen Walker | F | 62 | 6 years | |
Eva Barnett | F | 44 | 3 years | |
Mark Levine | M | 51 | 2 years | |
Juan Luciano | M | 62 | 8 years | |
Katherine Baicker | M | 52 | 13 years | |
Jamere Jackson | M | 54 | 8 years | |
George Golumbeski | M | 67 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 1 years |
Frank Torti | M | 45 |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | 5 years |
Daniel Skovronsky | M | 50 | 6 years | |
Andrew Fromkin | M | 58 |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | 5 years |
Barbara White | M | 73 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 11 years |
William Kaelin | M | 66 | 12 years | |
Christina Bertsch | F | - | - | |
Sheetal Patel | F | - | - | |
Ian Gourley | M | - | - | |
Maria Alba | M | - | - | |
Judy Roth | F | - | - | |
Jennifer Moseley | F | - | - | |
Lauren Schrier | F | - | - | |
Chau Cheng | M | - | - | |
Michael Elliott | M | - | 4 years | |
Donald Zakrowski | M | - | 12 years | |
Dominic Smethurst | M | 50 | - | |
Robert Conley | M | - | 7 years | |
Eric Venker | M | 37 | 4 years | |
Jay Stout | M | 61 | 1 years | |
Johna Norton | F | 57 | 7 years | |
William L. Macias | M | 66 | 3 years | |
Andy Deig | M | - | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
John Lechleiter | M | 70 | 38 years | |
Bryce D. Carmine | M | 72 | 29 years | |
Susan Mahony | M | 59 | 18 years | |
Ellen Marram | F | 77 | 17 years | |
Craig Millian | M | 56 | 4 years | |
Joshua Smiley | M | 54 | 5 years | |
Jeffrey A. Winton | M | - | 3 years | |
Jeffrey Balagna | M | 63 | 1 years | |
Jackson Tai | M | 73 | 10 years | |
Paris Panayiotopoulos | M | 50 | 3 years | |
Anne Nobles | M | 67 | 22 years | |
Gregory Davis | M | 70 | 20 years | |
Pamela Connealy | F | 63 | 2 years | |
Antoine Ezell | M | 55 | 20 years | |
Ted Jenkins | M | - | 4 years | |
Jennifer Fulk | F | - | 7 years | |
Frank M. Deane | M | 74 | 26 years | |
Carolyn Bertozzi | M | 57 | 4 years | |
Alex Michael Azar | M | 56 | 4 years | |
Franklyn Prendergast | M | 79 | 22 years | |
Robert A. Armitage | M | 75 | 13 years | |
Derica Rice | M | 59 | 14 years | |
R. Hoover | M | 77 | 9 years | |
Martin Feldstein | M | 84 | 10 years | |
Karen N. Horn | M | 80 | 29 years | |
Win Bischoff | M | 81 | 14 years | |
Douglas Oberhelman | M | 71 | 7 years | |
Jan Lundberg | M | 70 | 8 years | |
Richard Ernest Gilbert | M | - | 12 years | |
Mythili Koneru | M | 46 | 4 years | |
Jane Smith | F | - | 3 years | |
Meredith Harper | F | 52 | 4 years | |
Natalia Novac | F | - | 4 years | |
David M. Kendall | M | 62 | 7 years | |
Hoon-Mo Lee | M | 46 | 2 years | |
Jeremy Morgan | M | - | 3 years | |
Gudarz Davar | M | - | 3 years | |
Jeffrey Simmons | M | 56 | 29 years | |
Gregory D. Plowman | M | - | - | |
Adam Houghton | M | - | 10 years | |
Manu Chakravarthy | M | 50 | 2 years | |
Ann Cunningham | F | 56 | 14 years | |
Sarena S. Lin | F | 53 | - | |
Stephen Curtis | M | - | 1 years | |
Mary Jane Geiger | M | - | - | |
Eiry Roberts | M | 60 | 3 years | |
Tiffany Olson | F | 64 | 2 years | |
Michael Andriole | M | 51 | 16 years | |
Bronwen Mantlo | M | - | 4 years | |
Elaine Sullivan | M | 63 | 3 years | |
Michael R. Meadows | M | - | 35 years | |
Andrew Oxtoby | M | 50 | 4 years | |
John Johnson | M | 66 | 3 years | |
Thomas Bumol | M | 70 | 35 years | |
Rachel Humphrey | M | 62 | - | |
Mark Andersen | M | 53 | 11 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Bermuda | 5 | 5.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Peter Salzmann
- Personal Network